2. Academic Validation
  3. A novel Hsp70 inhibitor specifically targeting the cancer-related Hsp70-Bim protein-protein interaction

A novel Hsp70 inhibitor specifically targeting the cancer-related Hsp70-Bim protein-protein interaction

  • Eur J Med Chem. 2021 Aug 5:220:113452. doi: 10.1016/j.ejmech.2021.113452.
Ziqian Wang 1,  Ting Song 2,  Zongwei Guo 3,  Laura B Uwituze 1,  Yafei Guo 3,  Hong Zhang 3,  Hang Wang 3,  Xiaodong Zhang 1,  Hao Pan 1,  Tong Ji 1,  Fangkui Yin 1,  Sheng Zhou 1,  Jian Dai 1,  Zhichao Zhang 4
Affiliations

Affiliations

  • 1 State Key Laboratory of Fine Chemicals, Zhang Dayu School of Chemistry, Dalian University of Technology, Dalian, Liaoning, 116024, China.
  • 2 State Key Laboratory of Fine Chemicals, Zhang Dayu School of Chemistry, Dalian University of Technology, Dalian, Liaoning, 116024, China. Electronic address: [email protected].
  • 3 School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, 116024, China.
  • 4 State Key Laboratory of Fine Chemicals, Zhang Dayu School of Chemistry, Dalian University of Technology, Dalian, Liaoning, 116024, China. Electronic address: [email protected].
PMID: 33906046 DOI: 10.1016/j.ejmech.2021.113452
Abstract

Targeting cancer-related Hsp70-Bim protein-protein interactions (PPIs) offers a new strategy for the design of HSP70 inhibitors. Herein, we discovered a novel HSP70 Inhibitor, S1g-6, based on the established BH3 mimetics. S1g-6 exhibited sub-μM binding affinity toward HSP70 and selectively disrupted Hsp70-Bim PPI. The target specificity of S1g-6in situ was validated by affinity-based protein profiling, co-immunoprecipitation, and cell-based shRNA assays. S1g-6 specifically antagonized the ATPase activity of HSP70 upon recruiting Bim and showed selective Apoptosis induction in some Cancer cell lines over normal ones through suppression of some oncogenic clients of HSP70, representing a new class of antitumor candidates. Hsp70-Bim PPI exhibited cancer-dependent role as a potential anti-cancer target.

Keywords

Antitumor candidate; Cancer-related target; Hsp70 inhibitor; Hsp70-bim PPI.

Figures
Products